Description
Letrofemin contains an active substance called letrozole. It belongs to a group of medicines called aromatase inhibitors. It is a hormonal (or “endocrine”) breast cancer treatment.
Letrofemin reduces the amount of oestrogen by blocking an enzyme (“aromatase”) involved in the production of oestrogens and therefore may block the growth of breast cancer that needs oestrogens to grow.
Indications
Letrofemin is used to treat breast cancer in women who have gone through menopause i.e cessation of periods.
It is used to prevent cancer from happening again. It can be used as first treatment before breast cancer surgery in case immediate surgery is not suitable or it can be used as first treatment after breast cancer surgery or following five years treatment with tamоxifen. Letrofemin is also used to prevent breast tumour spreading to other parts of the body in patients with advanced breast cancer.
Subject to medical prescription.
Concentration and pharmaceutical form: 2,5 mg film-coated tablets
